TRCT
PROF

Tower Research Capital (TRC)’s Profound Medical PROF Stock Holding History

Tower Research Capital (TRC)’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Buy
+1,584
New +$10.6K ﹤0.01% 3976
2025
Q4 		– Sell
-365
Closed -$1.78K – 5487
2025
Q3 		$1.78K Buy
+365
New +$1.86K ﹤0.01% 4732
2025
Q1 		– Sell
-316
Closed -$2.37K – 5656
2024
Q4 		$2.37K Buy
+316
New +$2.43K ﹤0.01% 4855
2024
Q2 		– Sell
-103
Closed -$879 – 5940
2024
Q1 		$879 Sell
103
-312
-75% -$2.6K ﹤0.01% 5368
2023
Q4 		$3.52K Buy
+415
New +$3.94K ﹤0.01% 5069
2023
Q3 		– Sell
-3,004
Closed -$39.1K – 6167
2023
Q2 		$39.1K Buy
3,004
+2,688
+851% +$33.3K ﹤0.01% 2791
2023
Q1 		$3K Buy
+316
New +$3.66K ﹤0.01% 5227
2022
Q4 		– Sell
-3,100
Closed -$13K – 6259
2022
Q3 		$13K Buy
3,100
+1,047
+51% +$7.07K ﹤0.01% 4281
2022
Q2 		$15K Buy
2,053
+1,917
+1,410% +$15.2K ﹤0.01% 4086
2022
Q1 		$1K Sell
136
-127
-48% -$1.22K ﹤0.01% 5840
2021
Q4 		$3K Buy
+263
New +$3.28K ﹤0.01% 5477
2021
Q3 		– Sell
-530
Closed -$9K – 6076
2021
Q2 		$9K Buy
530
+473
+830% +$8.8K ﹤0.01% 4445
2021
Q1 		$1K Buy
+57
New +$1.37K ﹤0.01% 5204

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Tower Research Capital (TRC)'s PROF Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Profound Medical (PROF) in Q2 2026: 1,584 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #3976 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in PROF as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in PROF in Q1 2021 and has held it in 13 quarters since. The position peaked at $39.1K in Q2 2023. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • Tower Research Capital (TRC) held 1,584 shares of Profound Medical worth $10.5K as of Q2 2026.
  • Profound Medical was a new Tower Research Capital (TRC) position in Q2 2026.
  • Profound Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3976 holding.
  • Tower Research Capital (TRC) first reported a position in Profound Medical in Q1 2021 and has held it in 13 quarters since.
  • Tower Research Capital (TRC)'s Profound Medical position peaked at $39.1K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.